Suppr超能文献

相似文献

1
Efficacy of sulfamethoxypyridazine in a murine model of Pneumocystis carinii pneumonia.
Antimicrob Agents Chemother. 1998 Apr;42(4):934-5. doi: 10.1128/AAC.42.4.934.
2
Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
Antimicrob Agents Chemother. 1996 Apr;40(4):962-5. doi: 10.1128/AAC.40.4.962.
4
Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
AIDS. 1996 Aug;10(9):1046-7. doi: 10.1097/00002030-199610090-00020.
5
Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
Int J STD AIDS. 2009 Sep;20(9):652-3. doi: 10.1258/ijsa.2009.008470.
6
Use of fluoroquinolones for prophylaxis of murine Pneumocystis carinii pneumonia.
Antimicrob Agents Chemother. 1992 Feb;36(2):470-2. doi: 10.1128/AAC.36.2.470.
7
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):104-14. doi: 10.1097/00042560-199706010-00002.
8
Methotrexate and trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis.
J Rheumatol. 2011 Apr;38(4):777; author reply 778. doi: 10.3899/jrheum.100858.

引用本文的文献

1
Novel Ring Systems: Spiro[Cycloalkane] Derivatives of Triazolo- and Tetrazolo-Pyridazines.
Molecules. 2021 Apr 8;26(8):2140. doi: 10.3390/molecules26082140.
3
Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Antimicrob Agents Chemother. 2005 Feb;49(2):741-8. doi: 10.1128/AAC.49.2.741-748.2005.
4
In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species.
Antimicrob Agents Chemother. 2002 Jun;46(6):2029-31. doi: 10.1128/AAC.46.6.2029-2031.2002.

本文引用的文献

2
Severe toxic reactions associated with sulfamethoxypyridazine (kynex).
Ann Intern Med. 1959 Jul;51(1):60-7. doi: 10.7326/0003-4819-51-1-60.
3
Dihydropteroate synthase polymorphisms in Pneumocystis carinii.
J Infect Dis. 1997 Feb;175(2):482-5. doi: 10.1093/infdis/175.2.482.
5
Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
Antimicrob Agents Chemother. 1996 Apr;40(4):962-5. doi: 10.1128/AAC.40.4.962.
6
Trimethoprim/sulfamethoxazole desensitization.
Ann Pharmacother. 1996 Feb;30(2):184-6. doi: 10.1177/106002809603000214.
7
Evaluation of sulfa drugs against recombinant Pneumocystis carinii dihydropteroate synthetase and in vivo.
J Eukaryot Microbiol. 1996 Sep-Oct;43(5):40S. doi: 10.1111/j.1550-7408.1996.tb04976.x.
8
Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
Clin Infect Dis. 1995 Aug;21 Suppl 1:S44-8. doi: 10.1093/clinids/21.supplement_1.s44.
9
The scid mouse as an experimental model for the evaluation of anti-Pneumocystis carinii therapy.
J Antimicrob Chemother. 1995 Jul;36(1):137-55. doi: 10.1093/jac/36.1.137.
10
Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
N Engl J Med. 1993 Dec 23;329(26):1922-6. doi: 10.1056/NEJM199312233292604.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验